These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4637685)

  • 1. [Gliclazide, a new antidiabetic with hemobiologic and vascular properties].
    Plauchu M; Pousset G
    Lyon Med; 1972 Oct; 228(16):383-5. PubMed ID: 4637685
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study on Gliclazide, an antidiabetic with a double vascular and metabolic polarity].
    Simonin R
    Mars Med; 1972; 109(10):655-8. PubMed ID: 4659845
    [No Abstract]   [Full Text] [Related]  

  • 3. [The real problem in diabetes (trial of gliclazide, an original molecule with metabolic and vascular properties)].
    Masbernard A; Portal A
    Therapeutique; 1972 Nov; 48(9):569-73. PubMed ID: 4650526
    [No Abstract]   [Full Text] [Related]  

  • 4. [A new antidiabetic agent: glyclazide. A study of glycemic regulation].
    Bour H; Denard Y; Plauchu M; Rathery M; Simonin R; Thervet F; Warembourg H
    Nouv Presse Med; 1974 Feb; 3(5):249-51. PubMed ID: 4819946
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of gliclazide on platelet behavior].
    Verry M; Dechavanne M; Desnoyers P; Stoltz JF; Vainer H
    Nouv Presse Med; 1974 Oct; 3(33):2099-100. PubMed ID: 4471584
    [No Abstract]   [Full Text] [Related]  

  • 6. [Long term study of a new antidiabetic agent in 1183 cases].
    Riveline B
    Sem Hop Ther; 1974 Feb; 50(2):133-9. PubMed ID: 4612707
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diamicron].
    Journ Annu Diabetol Hotel Dieu; 1972; 13(0):343-9. PubMed ID: 4679568
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic trial of a new antidiabetic with vascular action: 1702 SE].
    Jaillard J; Warembourg H
    Lille Med; 1972 Oct; 17(9):Suppl 6:1332-6. PubMed ID: 4657429
    [No Abstract]   [Full Text] [Related]  

  • 9. The pharmacology of S 1702, a new highly effective oral antidiabetic drug with unusual properties. 2. Protective activity of S 1702 on the microvascular system in normal and diabetic rats.
    Duhault J; Lebon F
    Arzneimittelforschung; 1972 Oct; 22(10):1686-90. PubMed ID: 4677057
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical study of a new oral hypoglycemic agent: glypentide (UR-661)].
    Calvet JM; Matarrodona M; Bordas R
    Rev Iber Endocrinol; 1974; 21(124):347-62. PubMed ID: 4453782
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diabetes therapy with a new antidiabetic Pro-Diaban].
    Dols W
    Ther Ggw; 1976 Mar; 115(3):428-36. PubMed ID: 772866
    [No Abstract]   [Full Text] [Related]  

  • 12. [Glurenorm a new peroral antidiabetic agent belonging to the group of sulfonylurea compounds].
    Grujić M; Rizvanbegović B; Perinović M; Perinović ID
    Med Arh; 1976; 30(2):119-21. PubMed ID: 971371
    [No Abstract]   [Full Text] [Related]  

  • 13. A new antidiabetic agent.
    Gupta SD; Mukerjee AB
    J Indian Med Assoc; 1974 Dec; 63(11):357-9. PubMed ID: 4282091
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical study of a new sulfonylurea antidiabetic, glibornuride].
    Vernet A; Fabre J; Zahnd G
    Schweiz Rundsch Med Prax; 1972 Dec; 61(52):1599-607. PubMed ID: 4630563
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diamicron and micristin in the complex treatment of diabetes mellitus].
    Balabolkin MI; Golubiatnikova GA; Koroleva TV; Titova GP
    Ter Arkh; 1982; 54(10):32-6. PubMed ID: 7179117
    [No Abstract]   [Full Text] [Related]  

  • 16. [Significance of an oral antidiabetic with vascular action: gliclazide in the asymptomatic diabetes and patent diabetes].
    Journ Annu Diabetol Hotel Dieu; 1976 May; ():331-9. PubMed ID: 1011422
    [No Abstract]   [Full Text] [Related]  

  • 17. [Survey of 832 case records of diabetes of adult onset treated by Diamicron. Evolution of metabolism and weight].
    Estivals JP; Giraudet MC; Videau JY
    Journ Annu Diabetol Hotel Dieu; 1978; ():333-40. PubMed ID: 349228
    [No Abstract]   [Full Text] [Related]  

  • 18. [Progress in oral antidiabetic therapy].
    Rambert P
    Therapeutique; 1973 Nov; 49(9):555-6. PubMed ID: 4600034
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological and clinical evaluation of the activity and tolerance of a new oral antidiabetic compound, glydiazinamide or K 4024.
    Parodi FA
    Isr J Med Sci; 1972 Jun; 8(6):888-92. PubMed ID: 5051831
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical study with glypentide, new sulfonylurea hypoglycemic agent].
    Pou Torelló JM; Vilaclara JM
    Rev Iber Endocrinol; 1974; 21(125):427-30, 433-8, 441-2 passim. PubMed ID: 4608666
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.